Application of Adenosine Deaminase and γ-Interferon Release Assay in Pleural Fluid for the Diagnosis of Tuberculous Pleural Effusion in Patients Over 40 Years Old

References

• Menzies NA, Quaife M, Allwood BW, et al. Lifetime burden of disease due to incident tuberculosis: a global reappraisal including post-tuberculosis sequelae. Lancet Global Health. 2021;9(12):e1679–e1687. doi:10.1016/s2214-109x(21
   PubMed Web of Science ®Google Scholar
• Porcel J. Tuberculous pleural effusion. Lung. 2009;187(5):263–270. doi:10.1007/s00408-009-9165-3
   PubMed Web of Science ®Google Scholar
• Gopi A, Madhavan SM, Sharma SK, Sahn SA. Diagnosis and treatment of tuberculous pleural effusion in 2006. Chest. 2007;131(3):880–889. doi:10.1378/chest.06-2063
   PubMed Web of Science ®Google Scholar
• Skouras VS, Kalomenidis I. Pleural fluid tests to diagnose tuberculous pleuritis. Curr Opin Pulm Med. 2016;22(4):367–377. doi:10.1097/mcp.0000000000000277
   PubMed Web of Science ®Google Scholar
• Jiang CG, Wang W, Zhou Q, et al. Influence of age on the diagnostic accuracy of soluble biomarkers for tuberculous pleural effusion: a post hoc analysis. BMC Pulm Med. 2020;20(1):178. doi:10.1186/s12890-020-01219-2
   PubMed Web of Science ®Google Scholar
• Porcel JM, Esquerda A, Bielsa S. Diagnostic performance of adenosine deaminase activity in pleural fluid: a single-center experience with over 2100 consecutive patients. Eur J Intern Med. 2010;21(5):419–423. doi:10.1016/j.ejim.2010.03.011
   PubMed Web of Science ®Google Scholar
• Arpinar Yigitbas B, Satici C, Kosar AF. Adenosine deaminase cutoff value when diagnosing tuberculous pleurisy in patients aged 40 years and older. Clin Respir J. 2021;15(1):109–115. doi:10.1111/crj.13277
   PubMed Web of Science ®Google Scholar
• Klimiuk J, Krenke R. Rola biomarkerów w diagnostyce gruźliczego wysiękowegozapalenia opłucnej [Role of biomarkers in making the diagnosis of tuberculous pleurisy]. Pneumonol Alergol Pol. 2011;79(4):288–297. Polish.
   PubMedGoogle Scholar
• Zhang M, Li D, Hu ZD, Huang YL. The diagnostic utility of pleural markers for tuberculosis pleural effusion. Ann Translational Med. 2020;8(9):607. doi:10.21037/atm.2019.09.110
   PubMed Web of Science ®Google Scholar
• Solari L, Soto A, Van der Stuyft P. Van der Stuyft P. Performance of clinical prediction rules for diagnosis of pleural tuberculosis in a high-incidence setting. Trop Med Int Health. 2017;22(10):1283–1292. doi:10.1111/tmi.12932
   PubMed Web of Science ®Google Scholar
• Tay TR, Tee A. Factors affecting pleural fluid adenosine deaminase level and the implication on the diagnosis of tuberculous pleural effusion: a retrospective cohort study. BMC Infect Dis. 2013;13:546. doi:10.1186/1471-2334-13-546
   PubMed Web of Science ®Google Scholar
• Abrao FC, de Abreu IR, Miyake DH, Busico MA, Younes RN. Role of adenosine deaminase and the influence of age on the diagnosis of pleural tuberculosis. Int J Tuberc Lung Dis. 2014;18(11):1363–1369. doi:10.5588/ijtld.14.0257
   PubMed Web of Science ®Google Scholar
• Lee SJ, Kim HS, Lee SH, et al. Factors influencing pleural adenosine deaminase level in patients with tuberculous pleurisy. Am J Med Sci. 2014;348(5):362–365. doi:10.1097/maj.0000000000000260
   PubMed Web of Science ®Google Scholar
• Korczynski P, Klimiuk J, Safianowska A, Krenke R. Impact of age on the diagnostic yield of four different biomarkers of tuberculous pleural effusion. Tuberculosis. 2019;114:24–29. doi:10.1016/j.tube.2018.11.004
   PubMed Web of Science ®Google Scholar
• Losi M, Bossink A, Codecasa L, et al. Use of a T-cell interferon-gamma release assay for the diagnosis of tuberculous pleurisy. Eur Respir J. 2007;30(6):1173–1179. doi:10.1183/09031936.00067307
   PubMed Web of Science ®Google Scholar
• Wongtim S, Silachamroon U, Ruxrungtham K, et al. Interferon gamma for diagnosing tuberculous pleural effusions. Thorax. 1999;54(10):921–924. doi:10.1136/thx.54.10.921
   PubMed Web of Science ®Google Scholar
• Jiang J, Shi HZ, Liang QL, Qin SM, Qin XJ. Diagnostic value of interferon-gamma in tuberculous pleurisy: a metaanalysis. Chest. 2007;131(4):1133–1141. doi:10.1378/chest.06-2273
   PubMed Web of Science ®Google Scholar
• Sun J, Zhang H, Song Z, et al. The negative impact of increasing age and underlying cirrhosis on the sensitivity of adenosine deaminase in the diagnosis of tuberculous peritonitis: a cross-sectional study in eastern China. Int j Infect Dis. 2021;110:204–212. doi:10.1016/j.ijid.2021.07.061
   PubMed Web of Science ®Google Scholar
• Kim SB, Shin B, Lee JH, et al. Pleural fluid ADA activity in tuberculous pleurisy can be low in elderly, critically ill patients with multi-organ failure. BMC Pulm Med. 2020;20(1):13. doi:10.1186/s12890-020-1049-6
   PubMed Web of Science ®Google Scholar
• Porcel JM. Pleural fluid biomarkers: beyond the Light criteria. Clin Chest Med. 2013;34(1):27–37. doi:10.1016/j.ccm.2012.11.002
   PubMed Web of Science ®Google Scholar
• Gelalcha AG, Kebede A, Mamo H. Light-emitting diode fluorescent microscopy and Xpert MTB/RIF® assay for diagnosis of pulmonary tuberculosis among patients attending Ambo hospital, west-central Ethiopia. BMC Infect Dis. 2017;17(1):613. doi:10.1186/s12879-017-2701-5
   PubMedGoogle Scholar
• Porcel JM, Light RW. Derrame pleural paraneumónico y empiema en adultos: guía práctica[Parapneumonic pleural effusions and empyema in adults: current practice]. Rev Clin Esp. 2009;209(10):485–494. doi:10.1016/s0014-2565(09)72634-7. Spanish.
   PubMed Web of Science ®Google Scholar
• Lei X, Wang J, Yang Z, Zhou S, Xu Z. Diagnostic Value of Pleural Effusion Mononuclear Cells Count and Adenosine Deaminase for Tuberculous Pleurisy Patients in China: a Case-Control Study. Front med. 2019;6:301. doi:10.3389/fmed.2019.00301
   Web of Science ®Google Scholar
• Ling DI, Flores LL, Riley LW, Pai M. Commercial nucleic-acid amplification tests for diagnosis of pulmonary tuberculosis in respiratory specimens: meta-analysis and meta-regression. PLoS One. 2008;3(2):e1536. doi:10.1371/journal.pone.0001536
   PubMed Web of Science ®Google Scholar
• Demirer E, Miller AC, Kunter E, Kartaloglu Z, Barnett SD, Elamin EM. Predictive models for tuberculous pleural effusions in a high tuberculosis prevalence region. Lung. 2012;190(2):239–248. doi:10.1007/s00408-011-9342-z
   PubMed Web of Science ®Google Scholar
• Xu HY, Li CY, Su SS, et al. Diagnosis of tuberculous pleurisy with combination of adenosine deaminase and interferon-γ immunospot assay in a tuberculosis-endemic population: a prospective cohort study. Medicine. 2017;96(47):e8412. doi:10.1097/md.0000000000008412
   PubMed Web of Science ®Google Scholar
• Beukes A, Shaw JA, Diacon AH, Irusen EM, Koegelenberg CFN. The Utility of Pleural Fluid Lactate Dehydrogenase to Adenosine Deaminase Ratio in Pleural Tuberculosis. Respir Int Rev Thoracic Dis. 2021;100(1):59–63. doi:10.1159/000509555
   Google Scholar
• Chang KC, Chan MC, Leung WM, et al. Optimising the utility of pleural fluid adenosine deaminase for the diagnosis of adult tuberculous pleural effusion in Hong Kong. Hong Kong med j. 2018;24(1):38–47. doi:10.12809/hkmj176238
   PubMed Web of Science ®Google Scholar
• Hamada T, Sanaka M, Hata E, Hasegawa T. [Pleural adenosine deaminase levels in tuberculous pleurisy--its diagnostic performance under the different prevalences in the different age of population]. Japanese J Thoracic Cardiovascular Surg. 1998;46(1):51–57. doi:10.1007/bf03217722. Japanese.
   PubMedGoogle Scholar
• Keng LT, Shu CC, Chen JY, et al. Evaluating pleural ADA, ADA2, IFN-γ and IGRA for diagnosing tuberculous pleurisy. J Infect. 2013;67(4):294–302. doi:10.1016/j.jinf.2013.05.009
   PubMed Web of Science ®Google Scholar
• Zhang Q, Zhou C. Comparison of laboratory testing methods for the diagnosis of tuberculous pleurisy in China. Sci Rep. 2017;7(1):4549. doi:10.1038/s41598-017-04872-6
   PubMed Web of Science ®Google Scholar
• Krenke R, Safianowska A, Paplinska M, et al. Pleural fluid adenosine deaminase and interferon gamma as diagnostic tools in tuberculosis pleurisy. J Physiol Pharmacol. 2008;59(Suppl 6):349–360.
   PubMedGoogle Scholar
• Liao M, Yang Q, Zhang J, et al. Gamma interferon immunospot assay of pleural effusion mononuclear cells for diagnosis of tuberculous pleurisy. Clin Vaccine Immunol. 2014;21(3):347–353. doi:10.1128/cvi.00680-13
   PubMedGoogle Scholar
• Yang X, Zhang J, Liang Q, et al. Use of T-SPOT.TB for the diagnosis of unconventional pleural tuberculosis is superior to ADA in high prevalence areas: a prospective analysis of 601 cases. BMC Infect Dis. 2021;21(1):4. doi:10.1186/s12879-020-05676-2
   PubMed Web of Science ®Google Scholar
• Mollo B, Jouveshomme S, Philippart F, Pilmis B. Biological markers in the diagnosis of tuberculous pleural effusion. Ann Biol Clin (Paris). 2017;75(1):19–27. doi:10.1684/abc.2016.1201
   PubMed Web of Science ®Google Scholar
• Feng M, Sun F, Wang F, Cao G. The diagnostic effect of sequential detection of ADA screening and T-SPOT assay in pleural effusion patients. Artif Cells, Nanomed Biotechnol. 2019;47(1):3272–3277. doi:10.1080/21691401.2019.1647221
   PubMed Web of Science ®Google Scholar
• Santos AP, Corrêa RDS, Ribeiro-Alves M, et al. Application of Venn’s diagram in the diagnosis of pleural tuberculosis using IFN-γ, IP-10 and adenosine deaminase. PLoS One. 2018;13(8):e0202481. doi:10.1371/journal.pone.0202481
   PubMed Web of Science ®Google Scholar
• Li Y, Xu H, Su S, et al. Clinical validation of a highly sensitive assay to detect EGFR mutations in plasma cell-free DNA from patients with advanced lung adenocarcinoma. PLoS One. 2017;12(8):e0183331. doi:10.1371/journal.pone.0183331
   PubMed Web of Science ®Google Scholar
• Tong X, Li Z, Zhao J, Liu S, Fan H. The value of single or combined use of pleural fluid interferon gamma release assay in the diagnosis of tuberculous pleurisy. Trop Med Int Health. 2021;26(11):1356–1366. doi:10.1111/tmi.13659
   PubMed Web of Science ®Google Scholar